CREBBP and Rubinstein-Taybi syndrome: The epigenetic dysregulation caused by CBP/p300 mutations in RSTS leads to widespread transcriptional changes, affecting the expression of numerous developmental genes, cell cycle regulators, and other key pathways, ultimately resulting in the diverse clinical features of the syndrome (Korzus, 2017; Van Gils et al., 2021).